baber/WOPTO huggingface dataset:
Patent EP-1342294-B1 (EP)
Inventor: ROY APURBA
IPC: H05K5/00
Filed: 2001-08-20
Granted: 2007-11-28
Abstract: In accordance with the invention, a low impedance surface-mount connector comprises a length of cylindrical rod having an I-shaped cross section. The device permits interconnection by pick-and-place techniques, and the interconnection has advantageous qualities of low resistance, low inductance, mechanical compliance and ease of manufacture. A first circuit device having one or more circuit components is interconnected with a second circuit device by surface mounting such connectors on the first circuit device, providing corresponding solder pads on the second circuit device, and mounting the connectors of the first circuit device onto the pads of the second.
Patent EP-1326520-B1 (EP)
Inventor: BILLSKOG PATRIK
IPC: A47L9/14
Filed: 2001-09-11
Granted: 2010-03-10
Abstract: A dust container comprising a bag (10) of air permeable, filtering material having an opening which dust-laden air flows into the bag, and a collar (11) connected to the bag having a collar opening that is mainly coaxial with the gag opening. The collar is provided with two opposite, mainly parallel, edge parts, an upper edge part and a lower edge part, and the upper edge part is provided with a handle portion (24) by which the dust container is pulled out of the vacuum cleaner. The collar close to the upper edge part is provided with at least one tab (18) extending sideways of the parallel edge parts and which by a bending line (19) is connected to the collar, and several recesses are positioned at the upper or lower edge part.
Patent EP-1399488-B1 (EP)
Inventor: CHARMOT DOMINIQUE
IPC: C08F2/00
Filed: 2001-09-26
Granted: 2005-07-20
Abstract: Control agents that have a nitrogen-nitrogen bond in a cyclic ring covalently bonded to a thiocarbonyl moiety are provided for living-type free radical polymerization without a bimodal molecular weight distribution at high monomer conversions. These control agents provide superior properties for the production of block polymers having narrow molecular weight distributions.
Patent EP-1282609-B1 (EP)
Inventor: TENG CHE-MING
IPC: A61K31/496
Filed: 2001-05-08
Granted: 2008-12-17
Abstract: Piperazinedione compounds (I) are new. Piperazinedione compounds of formula(I) are new. [Image] a and b : single or double bond; A : H, CH(RaRb) or C(RaRb); Z : R 3O-(Ar)-B or C(Rc); B : CH(Rc); Ar : heteroaryl; R 3H, alkyl, (hetero)aryl, C(O)Rd, C(O)ORd, C(O)NRdRe or SO 2Rd; R 1 and R 2H, C(O)Rd, C(O)ORd, C(O)NRdRe or SO 2Rd; Ra, Rb, Rc, Rd and Re : H, alkyl, (hetero)aryl or (hetero)cyclyl; optionally Ra+Rb, R 1+Ra and R 1+Rb : (hetero)cyclyl. provided that when b is a single bond, then A is H or CH(RaRb) or when b is a double bond, then A is C(RaRb) and when a is a single bond then Z is R 3O-(Ar)-B and when a is a double bond, Z is C(Rc). An independent claim is also included for treating tumor, involving administering a piperazinedione compound of formula (II) to a subject. [Image] Z' : CH(R cR d) or C(R cR d); R 1> and R 2>H, C(O)Re, C(O)ORe, C(O)NReRf or SO 2Re; R c, R d, Re and Rf : Ra; R 1>+Ra and R 1>+Rb : (hetero)cyclyl. When a is a single bond then Z' is CH(R cR d) and when a is a double bond, Z' is C(R cR d). Provided that if a is a single bond and b is a double bond, then one of R c and R d is H and other is heteroaryl. ACTIVITY : Cytostatic. The cytotoxic activities of (I) and taxol were tested on PC-3 cells. Cells were incubated in the presence of (I) in a serum-free medium for 24 hours. The cytotoxic activities were determined by the MTT assay. All compounds were active. The most potent (I) had an EC 5 0 value of about 0.3 micromolar, which is 30 times more potent than taxol. MECHANISM OF ACTION : Inhibitor of G 2/M progression of the cell cycle; Inhibitor of endothelial cell proliferation and angiogenesis effect; Inhibitor of polymerization of tubulin/microtubulin. Tubulin/microtubulin was incubated in the presence of (I) at a different concentrations in a solution (0.1 M MES, 1 mM EGTA, 0.5 mM MgCl 2, 0.1 mM EDTA and 2.5 M glycerol) at 37[deg]C. Then GTP was added to induce polymerization of tubulin/microtubulin. Optical density was measured at 350 nm at various time points to determine the degree of the polymerization. (I) inhibits the polymerization at 10 -> 6> - 10 -> 5> M.
Patent EP-1341223-B1 (EP)
Title: Dispositif de surveillance d'un polissage et dispositif de polissage
Inventor: MATSUKAWA EIJI
IPC: B24B37/013
Filed: 2001-11-07
Granted: 2006-08-16
Abstract: L'invention concerne une lumière de mesure émise par une source lumineuse (21), qui est dirigée sur une plaquette (2) à polir afin de détecter l'intensité spectrale de sa lumière réfléchie au moyen d'un capteur linéaire (31). Une unité de traitement de signaux (11) surveille le polissage de la plaquette (2) en fonction d'un signal de détection émis par le capteur linéaire (31) afin de détecter une fin de polissage de ladite plaquette (2). Une unité de commande (14) du mécanisme obturateur commande le moteur (13b) du mécanisme obturateur (13) en réponse au signal fin de polissage émis par l'unité de traitement de signaux (11) et avance un élément de protection (13a) vers le chemin optique de la lumière de mesure de façon à protéger ladite lumière de la plaquette (2). En conséquence, il est possible de réduire, sur un objet à polir, l'effet d'une lumière de mesure de surveillance d'un polissage.
Patent EP-1266135-B1 (EP)
Inventor: GRYTZ UWE
IPC: F02M51/06
Filed: 2001-12-15
Granted: 2004-08-04
Abstract: Electrovanne destinée à commander la soupape d'injection d'un moteur à combustion interne, qui possède un électroaimant (29), un induit mobile doté d'une plaque (28) et d'un axe (27) et un obturateur (25) de vanne pilote se déplaçant avec l'induit et coopérant avec un siège (24) de soupape pour l'ouverture et la fermeture d'un canal d'écoulement (17) de carburant d'une chambre de pression pilote (14) de la soupape d'injection (1). La plaque (28) d'induit est montée coulissante sur l'axe (27) d'induit sous l'effet de sa masse inerte dans la direction de fermeture de l'obturateur (25) de vanne pilote contre la force élastique d'un ressort de rappel (35) agissant sur la plaque (28) d'induit. Selon la présente invention, la plaque d'induit est pourvue d'un élément de réglage qui est placé sur une partie (42) de ladite plaque (28) opposée à l'électroaimant (29) et qui peut être ajusté par rapport à une face (41) de la plaque d'induit orientée vers l'électroaimant, dans la direction de coulissement de la plaque (28) d'induit, ce qui permet de pouvoir ajuster de manière simple la trajectoire de coulissement maximale de la plaque (28) d'induit.
Patent EP-1340836-B1 (EP)
Inventor: ANPO MASAKAZU
IPC: B01J21/02
Filed: 2001-11-13
Granted: 2010-10-06
Abstract: L'invention concerne un élément composite doté d'un substrat (12), avec film de mélange (14) à la surface du substrat, ce film (14) comprenant un mélange d'oxyde de bore et d'oxyde de titane photocatalytique, qui présente une capacité de transmission de la lumière élevée, et est incolore et transparent. On peut l'utiliser pour supprimer la réflexion de surface ou la teinte de polarisation, améliorer les caractéristiques de décomposition photocatalytique, et augmenter la vitesse d'amélioration de l'hydrophilie, entre autres.
Patent EP-1348210-B1 (EP)
Inventor: TALSTILA PEKKA
IPC: F21V8/00
Filed: 2001-12-04
Granted: 2006-07-26
Abstract: An indicator or advertising board (1) comprising a display component (3) of an essentially sheet-like, transparent material and an illuminating component implemented using light-emitting diodes (5). The light-emitting diodes (5) are located in the immediate vicinity of the edge of the sheet-like display component (3), to light the sheet through the edge. The diodes (5) are at least of types emitting red, blue, and green light. The device includes a control unit (6), or at least a connection to a control unit, intended to control the intensity of the light emitted by the variously coloured diodes in relation to each other, in order to display different hues of colour on the board (1).
Patent EP-1308531-B1 (EP)
Inventor: BRONFIN BORIS
IPC: C22C23/02
Filed: 2002-01-03
Granted: 2006-04-26
Abstract: A magnesium based alloy containing at least 85.4 wt% Mg, 4.7 to 7.3 wt% aluminum, 0.17 to 0.60 wt% manganese, 0.0 to 0.8 wt% zinc, 1.8 to 3.2 wt% calcium, 0.3 to 2.2 wt% tin, and 0.0 to 0.5 wt% strontium. The alloy may comprising up to 0.004 wt% iron, up to 0.001 wt% nickel, up to 0.003 wt% copper, or up to 0.03 wt% silicon. In addition, the alloy may comprise up to 0.001 wt% beryllium.
Patent EP-1333101-B1 (EP)
Inventor: FRANZEN JOCHEN
IPC: C12Q1/6827
Filed: 2002-02-01
Granted: 2007-03-28
Abstract: The invention concerns mass spectrometric analysis of known mutation sites in the genome, such as single nucleotide polymorphisms (SNPs). The invention uses minor amounts of primers with photocleavable linkers, intermixed with a major amounts of primers without linkers, to produce short mutation-containing DNA sequences by enzymatic amplification procedures such as polymerase chain reactions (PCR). After this single amplification procedure, the linker-containing PCR by-products are extracted, washed and photolytically cleaved. Short oligonucleotides are produced which facilitate mass spectrometric analysis. Additionally to the use of linkers, some types of primers may contain blockers which stop the polymerase copying process to achieve even shorter oligonucleotides for analysis. <IMAGE>
Patent EP-1291215-B1 (EP)
Inventor: SOMMER VOLKER DIPL-ING
IPC: B60J7/02
Filed: 2002-07-01
Granted: 2008-11-26
Abstract: The front (4) and side sections (7,8) of the sliding roof frame has water drain channels open at the top, with the channel in the front section accommodating a wind deflector in its non-extended neutral position. The pivot bearings for the wind deflector are formed in one piece with the frame front section and constructed to accommodate bearing necks fitted on the adjustment arms of the wind deflector. The bearings are installed in respective pairs in the two side members (5,6) of the frame front section, whereby all the bearings are located on a common alignment axis extending at right angles to the vertical center longitudinal plane of the frame (3).
Patent EP-1398076-B1 (EP)
Inventor: VILADOT PETIT JOSEP-LLUIS DR
IPC: D06M23/12
Filed: 2002-09-10
Granted: 2008-10-29
Abstract: Polyamide microcapsules having an average diameter of 0.0001-0.1 mm are prepared by mixing an aqueous phase containing diamines and/or triamines and surfactants with an oil phase containing dicarboxylic acids and wax particles to form an oil-in-water emulsion, such that a polycondensation reaction occurs at the interfacial boundaries to form polyamide microcapsules.  Polyamide microcapsules (I) having an average diameter of 0.1-5 mm are prepared by:  (a) preparing an aqueous phase in which diamines and/or triamines (A1) and surfactants (A2) are dissolved;  (b) preparing an oil phase in which dicarboxylic acids (B1), wax particles (B2) and optionally additives (B3) are dissolved; and (c) mixing (A) and (B) to form an oil-in-water emulsion such that a polycondensation reaction occurs at the interfacial boundaries to form polyamide microcapsules (I).
Patent EP-1308765-B1 (EP)
Inventor: HOOKMAN ROBERT A
IPC: G02B7/02
Filed: 2002-11-04
Granted: 2007-03-07
Abstract: A mount (100) includes a plurality of flexures disposed on a frame in pairs for securing an optical component to the frame. A first pair of flexures is disposed along a first axis (X) that intersects a center of the optical component, and a second pair of flexures is disposed along a second axis (Y) that intersects the center of the optical component. Each of the flexures is flexible in a direction substantially perpendicular to the flexure and allows movement of the optical component in the same direction as the axis upon which each flexure is disposed. Each flexure is further substantially rigid in all directions non-parallel the direction of the axis upon which each flexure is disposed. The alignment of pairs of flexures in this configuration minimizes the adverse effects of extreme vibrational and thermal distortions on the flatness of the optical component. <IMAGE>
Patent EP-1281641-B1 (EP)
Inventor: FANTINI CONTARDO
IPC: B65G21/18
Filed: 2002-07-04
Granted: 2005-05-25
Abstract: A drive system typically for band conveyors, comprising at least one motorized gear (33) arranged to engage a chain associated with the side of the conveyor (8), said at least one gear (33) consisting of a toothed wheel having its axis perpendicular to the plane of the conveyor, and circular involute profiles that engage conjugate straight-flanked teeth (3) associated with the chain structure. <IMAGE>
Patent EP-1400726-B1 (EP)
Inventor: BASTHOLM JEPPE CHRISTIAN
IPC: F16D65/28
Filed: 2002-09-22
Granted: 2005-03-30
Abstract: An actuator, preferably a linear actuator for furniture, comprises a brake spring (20) in the form of a helical spring having a plurality of windings wound around a cylindrical element (10) of plastics rotatable at least during braking, said spring being tightened around the cylindrical element for braking. The frictional heat generated hereby can cause the plastics to be deformed, which adversely affects the braking power. <??>This is solved by providing the cylindrical element (10) consisting of plastics with an insert (12) of metal for carrying off the frictional heat preferably into other metal parts of the actuator that may serve as cooling faces. <??>To carry off heat additionally, it is proposed to arrange a second heat-conducting element (18) in intimate contact with the outer side of the spring (20), said element being likewise connected with other metal parts of the actuator that may serve as cooling faces. <IMAGE>
Patent EP-1227589-B1 (EP)
Inventor: GUPTA SANDEEP K
IPC: H03K17/14
Filed: 2002-01-10
Granted: 2010-03-17
Abstract: The present invention relates to a replica network (400) for linearizing switched capacitor circuits. A bridge circuit (406) with a MOSFET resistor (424) disposed in a resistor branch of the bridge circuit is provided. A noninverting terminal of an operational amplifier (408) is connected to a first node (B) of the bridge circuit and an inverting terminal of the operational amplifier is connected to a second note (D) of the bridge circuit. The second node is separated from the first node by another node (C) of the bridge circuit. An output of the operational amplifier (408) is provided to a gate terminal of the MOSFET resistor (424) and to the gate terminal of the MOSFET switch (204) in a switched capacitor circuit, thereby controlling the resistance of the MOSFET switch so that it is independent of the signal voltage. In this manner, the replica network of the present invention linearizes the switched capacitor circuit. In this manner, the replica network of the present invention linearizes the switched capacitor circuit.
Patent EP-1241192-B1 (EP)
Inventor: TAKAI MASATO
IPC: C08F218/08
Filed: 2002-03-13
Granted: 2005-10-26
Abstract: The present invention provides a method for manufacturing an ethylene-vinyl acetate that includes:   (a) introducing an ethylene containing gas and a vinyl acetate containing liquid into a heat exchanger, said gas including ethylene vaporized from a polymerization solution; (b) bringing said gas into contact with said liquid in the heat exchanger so as to dissolve at least a portion of the ethylene in said gas into said liquid; and (c) introducing said liquid from the heat exchanger into the polymerization solution.   In this method, the ethylene containing gas and the vinyl acetate containing liquid flow in parallel with each other in the heat exchanger. <IMAGE>
Patent EP-1350839-B1 (EP)
Inventor: COLE STEWART
IPC: C12N1/36
Filed: 2002-04-05
Granted: 2010-06-02
Abstract: The present invention relates to a strain of  M. bovis  BCG or  M. microti,  wherein said strain has integrated part or all of the RD1 region responsible for enhanced immunogenicity of the tubercle bacilli, especially the ESAT-6 and CFP-10 genes. These strains will be referred as the  M. bovis  BCG::RD1 or  M. microti ::RD1 strains and are useful as a new improved vaccine for preventing tuberculosis and as a therapeutical product enhancing the stimulation of the immune system for the treatment of bladder cancer. These strains are also useful for the expression and presentation of heterologous antigens and molecule that are of therapeutic or prophylactic interest.
Patent EP-1360014-B1 (EP)
Title: Dispositif de distribution de produit fluide
Inventor: MILIAN ALEX
IPC: B05B11/00
Filed: 2002-01-16
Granted: 2006-05-31
Abstract: Dispositif de distribution de produit fluide comprenant: - un organe de distribution (1), tel qu'une pompe ou une valve, pourvu d'une tige d'actionnement (12), - un poussoir (2) monté rotatif sur et autour de la tige d'actionnement et pourvu d'un orifice de distribution (26), l'actionnement de l'organe de distribution s'opérant par appui sur le poussoir; - une bague de fixation (4) pour fixer l'organe de distribution sur un récipient (6), ladite bague comprenant des moyens d'accrochage (41, 42) destinés à coopérer avec un col de récipient (60), la bague de fixation (4) comprenant au moins un profil interne de verrouillage (45, 46) et le poussoir comprend au moins un organe de verrouillage (45, 46) et le poussoir comprend au moins un organe de verrouillage (22) en prise avec ledit au moins un profil interne pour empêcher l'actionnement du poussoir, caractérisé en ce que le poussoir (2) comprend une douille interne (21) pourvu dudit au moins un organe de verrouillage (22) et une jupe externe (25) concentrique à la douille interne et définissant l'orifice de distribution (26), la douille pénétrant dans la bague de fixation et la jupe étant adaptée à venir entourer la bague de fixation.
Patent EP-1379853-B1 (EP)
Inventor: ROBERTS DARYL L
IPC: G01N15/02
Filed: 2002-02-07
Granted: 2008-04-09
Abstract: A method for automating the process of impaction of particles, recovering samples from a plurality of impaction cups (32A-32H), and washing the cups (32A-32H) for a new cycle. The process includes steps of agitating the solvent used for dissolving samples, removing samples and transferring the samples to vials used in an analyzing instrument.
Patent EP-1370290-B1 (EP)
Inventor: RENNER WOLFGANG A
IPC: A61K38/095
Filed: 2002-01-21
Granted: 2016-06-01
Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.
Patent EP-1372575-B1 (EP)
Inventor: ZECH JOACHIM
IPC: A61K6/90
Filed: 2002-03-28
Granted: 2005-11-23
Abstract: The invention relates to a two-component addition-cured silicon impression compound, comprising the following when both components are mixed: (a) between 1 and 35 wt. % of at least one organopolysiloxane comprising at least two unsaturated groups in the molecule; (b) between 1 and 10 wt. % of at least one organohydrogenpolysiloxane comprising at least two SiH groups in the molecule; (c) between 0.00005 and 0.05 wt. % of at least one platinum catalyst, calculated as elementary platinum; (d) between 4 and 10 wt. % of at least one liquid paraffin or at least one white mineral oil, or of a mixture of at least one liquid paraffin and at least one white mineral oil; (e) between 50 and 90 wt. % of at least one filler, each respective percentage relating to the total weight of the silicon impression compound. According to the invention, one of the components before being mixed with the other component has a Brookfield viscosity ranging between 800 and 2000 Pa*s. The invention is characterized in that the silicon impression compound, when mixed, has a consistency stipulated by ISO 4823 of less then or equal to 35 mm.
Patent EP-1487770-B1 (EP)
Inventor: SINHA ARUN KUMAR
IPC: C07C41/18
Filed: 2002-03-27
Granted: 2007-12-12
Abstract: The present invention relates to neolignan (NEOLASA-I) 3-ethyl-2-methyl-3-(2'',4'',5''-trimethoxy-phenyl-1-(2',4',5'-trimethoxy)phenyl-1-propene and a process for the preparation of high purity, higher yield neolignan, alpha-asarone, 2,4,5-trimethoxy-phenyl propionone from beta-asarone or beta-asarone rich Acorus calamus oil containing alpha and gamma-asarone by hydrogenating and dimerizing by treatment with DDQ in presence of an organic acid.
Patent EP-1381601-B1 (EP)
Inventor: SUH KWEE HYUN
IPC: A61P31/04
Filed: 2002-04-25
Granted: 2006-01-18
Abstract: The present invention relates to a clathrate of azithromycin hydrate with 1,2-propyleneglycol of formula (I), a method for the manufacture thereof, and a pharmaceutical composition containing same. The inventive compound is much less hygroscopic than azithromycin hydrate or crystals known in the art, therefore, it can be useful for the preparation of a medicine for treating various microbial infections. wherein m ranges from 1 to 2 and n, from 0.30 to 0.45.
Patent EP-1395201-B1 (EP)
Inventor: GOMEZ ANDREINA P
IPC: A61F2/06
Filed: 2002-05-16
Granted: 2011-10-19
Abstract: The invention is directed to an expandable stent for implanting in a body lumen, such as a coronary artery, peripheral artery, or other body lumen. The invention provides for an intravascular stent having a plurality of cylindrical rings connected by undulating links. The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial strength sufficient to hold open an artery or other body lumen. The stent can be compressed or crimped onto a catheter to a very low profile since the peaks that are adjacent the curved portion of the undulating link are shorter than other peaks in the same cylindrical ring to prevent overlap yet still achieve a very low profile, tightly crimped stent onto a catheter.
Patent EP-1407202-B1 (EP)
Inventor: WISNIEWSKI RICHARD
IPC: F25D17/02
Filed: 2002-07-15
Granted: 2010-01-27
Abstract: A biopharmaceutical material cryopreservation system, including a flexible sterile container comprising a biocompatible polymeric material, and the flexible sterile container containing biopharmaceuticals materials, and a freezing system removably coupled to the flexible sterile container via a tapered slot and the freezing system thermally coupled to the biopharmaceutical materials via the flexible sterile container and the tapered slot; wherein the freezing system comprises a feedback loop constructed to control a dendritc freezing front velocity, within the biopharmaceutical materials, in a range from approximately 5 millimeters per hour to approximately 250 millimeters per hour based on feedback information from the temperature sensor. Also disclosed are methods of cryopreservation of biopharmaceutical materials, and methods of linearly scaling processes for cryopreservation of biopharmaceutical materials.